
In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Lee-Ann Farrell, Head of National Programmes at Johnson & Johnson, about what delivery will look like in practice when it comes to the National Cancer Plan, the 10-Year Health Plan, and the Life Sciences Sector Plan. The conversation ranges what comes next following the clear policy direction of the Plans, including how the system can move from ambition to implementation, particularly in ensuring innovation is adopted consistently and at pace across cancer care. Farrell discusses the role of innovative medicines within evolving care pathways – as ambitions grow around earlier diagnosis, improved outcomes, and care closer to home – as well the dual role of innovative medicines, both as drivers of better patient outcomes and as contributors to economic growth and system sustainability. You can listen to episode 262 to go here of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Trustworthy and novel AI in clinical trial planning, with Kris Kaneta

The cardio-renal-metabolic space and obesity as a chronic disease, with Ramy Younes

On the power of T-cells, with Cedrik Britten

Why everyone should care about longevity, with Boyang Wang
Free AI-powered recaps of pharmaphorum Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.